ES8500902A1 - Un procedimiento para la preparacion de un derivado del indol. - Google Patents

Un procedimiento para la preparacion de un derivado del indol.

Info

Publication number
ES8500902A1
ES8500902A1 ES520784A ES520784A ES8500902A1 ES 8500902 A1 ES8500902 A1 ES 8500902A1 ES 520784 A ES520784 A ES 520784A ES 520784 A ES520784 A ES 520784A ES 8500902 A1 ES8500902 A1 ES 8500902A1
Authority
ES
Spain
Prior art keywords
group
alkyl
compounds
hydrogen atom
indole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES520784A
Other languages
English (en)
Other versions
ES520784A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ES8500902A1 publication Critical patent/ES8500902A1/es
Publication of ES520784A0 publication Critical patent/ES520784A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72—Hydrazones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE UN DERIVADO DEL INDOL, DE FORMULA GENERAL (I), Y SUS SALES O SOLVATOS FISIOLOGICAMENTE ACEPTABLES.CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA GENERAL (II) O UN DERIVADO PROTEGIDO DEL MISMO, CON UNA AMINA DE FORMULA: R4R5NH.DE APLICACION EN EL TRATAMIENTO DE LA MIGRAINA.
ES520784A 1980-08-12 1983-03-18 Un procedimiento para la preparacion de un derivado del indol. Granted ES520784A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8026286 1980-08-12

Publications (2)

Publication Number Publication Date
ES8500902A1 true ES8500902A1 (es) 1984-11-01
ES520784A0 ES520784A0 (es) 1984-11-01

Family

ID=10515410

Family Applications (5)

Application Number Title Priority Date Filing Date
ES504693A Expired ES8301210A1 (es) 1980-08-12 1981-08-11 Un procedimiento para la preparacion de un derivado del indol.
ES513933A Expired ES8402268A1 (es) 1980-08-12 1982-07-13 Un procedimiento para la preparacion de un derivado del indol.
ES520784A Granted ES520784A0 (es) 1980-08-12 1983-03-18 Un procedimiento para la preparacion de un derivado del indol.
ES520783A Granted ES520783A0 (es) 1980-08-12 1983-03-18 Un procedimiento para la preparacion de un derivado del indol.
ES520785A Expired ES8500903A1 (es) 1980-08-12 1983-03-18 Un procedimiento para la preparacion de un derivado del indol.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES504693A Expired ES8301210A1 (es) 1980-08-12 1981-08-11 Un procedimiento para la preparacion de un derivado del indol.
ES513933A Expired ES8402268A1 (es) 1980-08-12 1982-07-13 Un procedimiento para la preparacion de un derivado del indol.

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES520783A Granted ES520783A0 (es) 1980-08-12 1983-03-18 Un procedimiento para la preparacion de un derivado del indol.
ES520785A Expired ES8500903A1 (es) 1980-08-12 1983-03-18 Un procedimiento para la preparacion de un derivado del indol.

Country Status (16)

Country Link
US (1) US4650810A (es)
JP (1) JPS5764669A (es)
AU (1) AU548467B2 (es)
BE (1) BE889929A (es)
CA (1) CA1169428A (es)
CH (1) CH651551A5 (es)
DE (1) DE3131728A1 (es)
DK (1) DK157920C (es)
ES (5) ES8301210A1 (es)
FR (1) FR2488607A1 (es)
IE (1) IE51491B1 (es)
IT (1) IT1171449B (es)
NL (1) NL8103769A (es)
NZ (1) NZ197996A (es)
SE (1) SE454880B (es)
ZA (1) ZA815540B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR79215B (es) * 1982-06-07 1984-10-22 Glaxo Group Ltd
GB8332435D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
EP0225726B1 (en) * 1985-11-08 1991-04-17 Glaxo Group Limited Indole derivatives
GB8530507D0 (en) * 1985-12-11 1986-01-22 Glaxo Group Plc Chemical compounds
US5270333A (en) * 1986-01-28 1993-12-14 Glaxo Group Limited Indole derivatives
GB8607824D0 (en) * 1986-03-27 1986-04-30 Glaxo Group Ltd Chemical compounds
CZ288351B6 (en) * 1990-06-07 2001-05-16 Astrazeneca Ab Nitrogenous heterocyclic compound, process of its preparation and use as well as a medicament containing thereof
CZ283018B6 (cs) * 1991-02-01 1997-12-17 Merck Sharp And Dohme Limited Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi
US5254383A (en) * 1992-09-14 1993-10-19 Allied-Signal Inc. Composites having improved penetration resistance and articles fabricated from same
FR2701026B1 (fr) * 1993-02-02 1995-03-31 Adir Nouveaux dérivés de l'indole, de l'indazole et du benzisoxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US5468768A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines
ES2084560B1 (es) * 1994-03-09 1997-01-16 Almirall Lab Procedimiento de preparacion de derivados el indol.
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
US20030096379A1 (en) * 2001-03-28 2003-05-22 Kilgore James L. Method for producing tryptamine derivatives
US20030198669A1 (en) * 2001-07-05 2003-10-23 R.T. Alamo Ventures I, Llc Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine
US20030017175A1 (en) * 2001-07-05 2003-01-23 R.T. Alamo Ventures I, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine
US6685951B2 (en) 2001-07-05 2004-02-03 R. T. Alamo Ventures I, Inc. Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
CA2508290C (en) * 2002-12-20 2017-02-28 Ciba Specialty Chemicals Holding Inc. Synthesis of amines and intermediates for the synthesis thereof
PL2425820T3 (pl) * 2007-02-11 2015-08-31 Map Pharmaceuticals Inc Sposób terapeutycznego stosowania dhe w celu umożliwienia szybkiego złagodzenia migreny przy jednoczesnym zminimalizowaniu profilu działań niepożądanych
US8173813B2 (en) * 2007-03-23 2012-05-08 Neuraxon, Inc. Quinolone and tetrahydroquinolone and related compounds having NOS inhibitory activity
US8293781B2 (en) 2007-03-29 2012-10-23 Daiichi Sankyo Company, Limited Indole derivatives having cPLA2 inhibiting activity and applications and production methods of the same
US20110171141A1 (en) * 2009-06-26 2011-07-14 Kellerman Donald J Administration of dihydroergotamine mesylate particles using a metered dose inhaler
DK2734634T3 (da) 2011-07-22 2019-10-21 Univ Chicago Igf-1 til anvendelse til behandling af migræne
EP2935280A4 (en) 2012-12-21 2016-05-25 Map Pharmaceuticals Inc 8'-HYDROXY-DIHYDROERGOTAMINE COMPOUNDS AND COMPOSITIONS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3182071A (en) * 1961-06-27 1965-05-04 Warner Lambert Pharmaceutical Acylated indole derivatives
US3472870A (en) * 1966-08-29 1969-10-14 Mead Johnson & Co Sulfonamidotryptamines
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
ZA815540B (en) 1983-03-30
NL8103769A (nl) 1982-03-01
CH651551A5 (fr) 1985-09-30
DK157920B (da) 1990-03-05
SE454880B (sv) 1988-06-06
ES520785A0 (es) 1984-11-01
ES8500903A1 (es) 1984-11-01
FR2488607B1 (es) 1984-11-16
NZ197996A (en) 1985-08-16
ES513933A0 (es) 1984-01-16
ES504693A0 (es) 1982-12-01
DE3131728A1 (de) 1982-03-11
ES520784A0 (es) 1984-11-01
DK157920C (da) 1990-08-06
IT1171449B (it) 1987-06-10
ES8402268A1 (es) 1984-01-16
IT8149084A0 (it) 1981-08-11
DK357081A (da) 1982-02-13
ES8504706A1 (es) 1985-05-01
JPH0247462B2 (es) 1990-10-19
AU548467B2 (en) 1985-12-12
SE8104781L (sv) 1982-02-13
ES520783A0 (es) 1985-05-01
IT8149084A1 (it) 1983-02-11
BE889929A (fr) 1982-02-11
US4650810A (en) 1987-03-17
JPS5764669A (en) 1982-04-19
ES8301210A1 (es) 1982-12-01
IE51491B1 (en) 1987-01-07
CA1169428A (en) 1984-06-19
DE3131728C2 (es) 1992-04-30
IE811830L (en) 1982-02-12
FR2488607A1 (fr) 1982-02-19
AU7399481A (en) 1982-02-18

Similar Documents

Publication Publication Date Title
IE811830L (en) Indoles.
IE811831L (en) Indoles.
ES469952A1 (es) Un procedimiento para la preparacion de aminoalquiltiofenos
DE3363244D1 (en) Compounds, process for their preparation and their use as pharmaceutical preparations
ES467288A1 (es) Un procedimiento para la preparacion de nuevas n-(aminoal- cohil sustituido)-2-oxo-1-pirrolidinacetamidas.
ES8100261A1 (es) Un procedimiento para la preparacion de un indol
ES8609247A1 (es) Un procedimiento para la preparacion de derivados del indol
ATE33838T1 (de) Thiazolidinderivate, ihre herstellung und diese enthaltende zusammensetzungen.
ES8300699A1 (es) Procedimiento para la preparacion de derivados del indol.
SE398348B (sv) Forfarande for framstellning av substituerade pleuromutiliner
IL98681A (en) Pharmaceutical compositions comprising hydroxamate derivatives for iron removal from mammalian cells and from pathogenic organisms and some novel hydroxamate derivatives
SE7605361L (sv) Sett att framstella nya n-substituerade fenylpiperazinderivat
ES8200648A2 (es) Procedimiento de preparacion de compuestos opacificantes para radiografia y similares
GB1353536A (en) Antiviral compositions containing bisbasic ethers and thioethers of xanthene and xanthen-9-ones and methods of treating viruses therewith
ES451209A1 (es) Procedimiento de fabricacion de sulfoximidas sustituidas y sus sales medicamentosas.
NZ240272A (en) Piperazine derivatives; pharmaceutical compositions and preparatory processes
SE7412163L (es)
FI871253A0 (fi) 1-/3-(2-dialkylaminoetoxi)-2 -tienyl/-3-fenyl-1-propanoner och deras syraadditionssalter, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska sammansaettningar.
HUT43068A (en) Process for preparing 5-amino-alkyl-beta-carboline derivatives and pharmaceutical compositions containing them
ES463797A1 (es) Procedimiento para la preparacion de o-(2-hidroxipropil)- aldoximas sustituidas con radicales basicos
ATE21511T1 (de) Cyclische amide.
ES481505A1 (es) Un metodo de preparacion de un eter aminofenilico.
ES481209A1 (es) Un procedimiento para preparar benzoxepinas.
GB2005250A (en) (1-Alkylpyrrolyl-2)thio- acetamides
ES481741A1 (es) Procedimiento para la obtencion de o-(amino alquil) oximas diaromaticas.